Evidence map›Paper›PMID 25496767›Full record

Trial reportEuropean urology2015

Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial.

Bernard H Bochner, Guido Dalbagni, Daniel D Sjoberg, Jonathan Silberstein, Gal E Keren Paz, S Machele Donat, Jonathan A Coleman, Sheila Mathew, Andrew Vickers, Geoffrey C Schnorr and 5 more

3 registry-linked trialsAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in European urology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 244 papers, 19 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
244citing papers in PubMed, 19 pooled it
41.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01076387 phase3completednot on this map

A Prospective, Randomized Trial Comparing Robotic and Open Radical Cystectomy

TypeinterventionalSponsorMemorial Sloan Kettering Cancer CenterRan2010 to 2020Enrolled124ConditionsBladder CancerArmsopen radical cystectomy, robotic-assisted radical cystectomy
NCT02572804 naunknown statusnot on this map

A Randomised Controlled Trial of Thoracic Epidural Analgesia Versus Surgically Placed Rectus Sheath Catheters for Open Radical Cystectomy: Is There a Difference in Patient Outcomes?

TypeinterventionalSponsorVancouver Coastal HealthRan2015 to 2017Enrolled160ConditionsBladder Cancer, Postoperative PainArmsEpidural, Rectus Sheath Catheters
NCT05324033 completednot on this mapstarted 2022, after this paper: background citation

Sensitivity of Multiparametric MRI in Differentiation Between Muscle Invasive and Non-muscle Invasive Urinary Bladder Cancer

TypeobservationalSponsorHelwan UniversityRan2022 to 2023Enrolled30ConditionsCancer, BladderArmsmultiparametric MRI on the bladder, diagnostic cystoscopy +/- TURBT
3 · Its place in the literature

Who cites it

244 citing papers in PubMed, 19 syntheses or guidelines pooled it, 590 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Essential Japanese Guidelines for the Prevention of Perioperative Infections in the Urological Field: 2023 Edition.International journal of urology : official journal of the Japanese Urological Association · 2025
    Guideline
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Comparison of Robotic vs Open Cystectomy: A Systematic Review.Bladder cancer (Amsterdam, Netherlands) · 2023
    Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Pooled it
  18. Robotic versus open radical cystectomy for bladder cancer in adults.The Cochrane database of systematic reviews · 2019
    Pooled it
  19. Pooled it
  20. Trial

184 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Bernard H BochnerUrology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: bochnerb@mskcc.org.
Guido DalbagniUrology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Daniel D SjobergDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Jonathan SilbersteinUrology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Urology, Tulane University School of Medicine, New Orleans, LA, USA.
Gal E Keren PazUrology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
S Machele DonatUrology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Jonathan A ColemanUrology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Sheila MathewUrology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Andrew VickersDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Geoffrey C SchnorrDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Michael A FeuersteinUrology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Bruce RapkinDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Raul O ParraUrology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Harry W HerrUrology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Vincent P LaudoneUrology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Memorial Sloan Kettering Cancer Center · USAlbert Einstein College of Medicine · USTulane University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
UROLOGY ONCOLOGY RESEARCH TRAINING GRANTT32CA082088 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Brett Stewart Carver · 1999 to 2026
$7.1M
NCI NIH HHS P30 CA008748NCI NIH HHS T32 CA082088
6 · The paper itself

Abstract

backgroundOpen radical cystectomy (ORC) and urinary diversion in patients with bladder cancer (BCa) are associated with significant perioperative complication risk.

objectiveTo compare perioperative complications between robot-assisted radical cystectomy (RARC) and ORC techniques. DESIGN, SETTING, AND

participantsA prospective randomized controlled trial was conducted during 2010 and 2013 in BCa patients scheduled for definitive treatment by radical cystectomy (RC), pelvic lymph node dissection (PLND), and urinary diversion. Patients were randomized to ORC/PLND or RARC/PLND, both with open urinary diversion. Patients were followed for 90 d postoperatively.

interventionStandard ORC or RARC with PLND; all urinary diversions were performed via an open approach. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Primary outcomes were overall 90-d grade 2-5 complications defined by a modified Clavien system. Secondary outcomes included comparison of high-grade complications, estimated blood loss, operative time, pathologic outcomes, 3- and 6-mo patient-reported quality-of-life (QOL) outcomes, and total operative room and inpatient costs. Differences in binary outcomes were assessed with the chi-square test, with differences in continuous outcomes assessed by analysis of covariance with randomization group as covariate and, for QOL end points, baseline score. RESULTS AND LIMITATIONS: The trial enrolled 124 patients, of whom 118 were randomized and underwent RC/PLND. Sixty were randomized to RARC and 58 to ORC. At 90 d, grade 2-5 complications were observed in 62% and 66% of RARC and ORC patients, respectively (95% confidence interval for difference, -21% to -13%; p=0.7). The similar rates of grade 2-5 complications at our mandated interim analysis met futility criteria; thus, early closure of the trial occurred. The RARC group had lower mean intraoperative blood loss (p=0.027) but significantly longer operative time than the ORC group (p<0.001). Pathologic variables including positive surgical margins and lymph node yields were similar. Mean hospital stay was 8 d in both arms (standard deviation, 3 and 5 d, respectively; p=0.5). Three- and 6-mo QOL outcomes were similar between arms. Cost analysis demonstrated an advantage to ORC compared with RARC. A limitation is the setting at a single high-volume, referral center; our findings may not be generalizable to all settings.

conclusionsThis trial failed to identify a large advantage for robot-assisted techniques over standard open surgery for patients undergoing RC/PLND and urinary diversion. Similar 90-d complication rates, hospital stay, pathologic outcomes, and 3- and 6-mo QOL outcomes were observed regardless of surgical technique. PATIENT SUMMARY: Of 118 patients with bladder cancer who underwent radical cystectomy, pelvic lymph node dissection, and urinary diversion, half were randomized to open surgery and half to robot-assisted laparoscopic surgery. We compared the rate of complications within 90 d after surgery for the open group versus the robotic group and found no significant difference between the two groups.

trial registrationClinicalTrials.gov identifier NCT01076387, www.clinicaltrials.gov.

Indexed as

AdultAgedAged, 80 and overBlood Loss, SurgicalCystectomyFemaleHumansLaparoscopyLymph Node ExcisionMaleMiddle AgedOperative TimePelvisPostoperative ComplicationsProspective StudiesQuality of LifeBladder cancerComplicationsCystectomyLymph node dissectionQuality of lifeRandomized controlled trialRobot assistedRoboticUrinary diversion

Identifiers

PMID25496767
PMCPMC4424172
OpenAlexW2045559857

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.